136727-12-3 Usage
General Description
BENZO[D]OXAZOL-2-YL-N-METHYLMETHANAMINE, also known as MEOP or 2-Methylbenzoxazole-6-carboxamidine, is a chemical compound that belongs to the class of benzoxazole derivatives. It is used in pharmaceutical research and development as a building block for the synthesis of various pharmaceutical compounds and drug candidates. MEOP has been studied for its potential applications in the treatment of various medical conditions, including cancer and neurological disorders. Its chemical structure and properties make it a valuable intermediate in organic synthesis and medicinal chemistry, with potential for further exploration in drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 136727-12-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,6,7,2 and 7 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 136727-12:
(8*1)+(7*3)+(6*6)+(5*7)+(4*2)+(3*7)+(2*1)+(1*2)=133
133 % 10 = 3
So 136727-12-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H10N2O/c1-10-6-9-11-7-4-2-3-5-8(7)12-9/h2-5,10H,6H2,1H3
136727-12-3Relevant articles and documents
Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
-
, (2008/06/13)
Vitronectin receptor antagonists having the formula: STR1 which are useful for the treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor, such as osteoporsis.
Substituted benzimidazole derivatives possessing Class III antiarrhythmic activity
-
, (2008/06/13)
This invention relates to N-heteroalkyl-substituted 1-aryloxy-2-propanolamine and proplyamine derivatives possessing anti-arrhythmic activity, to pharmaceutical compositions and to method for production thereof.
